#Biotech Synageva Has Eliminated Major Risks To Its Business - http://t.co/VSZUGI0GcD
July 03, 2013
Publicité
/http%3A%2F%2Fstatic.cdn-seekingalpha.com%2Fuploads%2F2013%2F7%2F2%2Fsaupload_Screen-Shot-2013-07-02-at-9.44.05-AM_thumb1.png)
Synageva Has Eliminated Major Risks To Its Business
We last covered Synageva BioPharma ( GEVA) in early January, arguing that the company faced fundamental risks that made its valuation a concern moving forward. But in the months since our last report, a number of changes to the Synageva story have improved our outlook on the orphan drug developer.